Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

42

Revenue 2017

Cialis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cialis was produced by Lilly.

Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive

Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive Strattera (atomoxetine) and erectile dysfunction therapy Cialis (tadalafil).

Lilly pilots enhanced online trial information

Lilly pilots enhanced online trial information The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with

Transition takes on Lilly muscle-boosting drug

Transition takes on Lilly muscle-boosting drug In the past, Lilly has tested SARMs in tandem with its Cialis (tadalafil) drug for erectile dysfunction (ED), while in recent years there has been growing interest in TRT to help

Pfizer targets women in Viagra campaign

Pfizer targets women in Viagra campaign Sales have fallen since then due in part to the availability of other branded ED treatments, such as Lilly's Cialis (tadalafil).

EMA backs 15 new medicines for use in EU

EMA backs 15 new medicines for use in EU Tadalafil is the active ingredient of Lilly's Cialis. In addition to the positive opinion for Egranli, Teva managed recommendation for three new hybrid treatments for respiratory diseases.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics